Nuveen Asset Management, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$220,698
-75.6%
42,118
-75.6%
0.00%
Q4 2023$904,000
-59.8%
172,849
+21.1%
0.00%
-100.0%
Q3 2023$2,250,411
+75.0%
142,702
+115.8%
0.00%
Q2 2023$1,285,704
+49791.5%
66,137
-27.2%
0.00%
-100.0%
Q1 2023$2,577
+13.2%
90,822
+16.5%
0.00%0.0%
Q4 2022$2,277
-99.9%
77,932
+20.0%
0.00%0.0%
Q3 2022$1,715,000
-43.2%
64,919
-4.4%
0.00%0.0%
Q2 2022$3,017,000
+46.7%
67,895
+61.5%
0.00%0.0%
Q1 2022$2,057,000
+7.8%
42,036
+1.0%
0.00%0.0%
Q4 2021$1,909,000
-28.2%
41,622
-12.6%
0.00%0.0%
Q3 2021$2,658,000
+27.8%
47,648
-1.9%
0.00%0.0%
Q2 2021$2,079,000
-5.6%
48,584
-7.9%
0.00%0.0%
Q1 2021$2,202,000
-8.1%
52,743
+2.5%
0.00%0.0%
Q4 2020$2,397,000
+13.6%
51,476
+3.6%
0.00%0.0%
Q3 2020$2,110,000
-13.1%
49,681
-1.8%
0.00%0.0%
Q2 2020$2,428,000
+19.1%
50,592
+14.2%
0.00%0.0%
Q1 2020$2,039,000
-21.4%
44,316
+2.6%
0.00%0.0%
Q4 2019$2,595,000
+4.9%
43,205
-1.2%
0.00%0.0%
Q3 2019$2,474,000
+0.8%
43,738
-0.7%
0.00%0.0%
Q2 2019$2,454,00044,0680.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Hudson Executive Capital LP 1,323,794$79,534,0003.54%
Park West Asset Management LLC 1,171,880$70,406,0002.96%
Matarin Capital Management, LLC 170,008$10,214,0000.98%
Smith, Graham & Co., Investment Advisors, LP 140,014$8,412,0000.82%
Capital Impact Advisors, LLC 33,725$2,026,0000.71%
U S GLOBAL INVESTORS INC 18,800$1,130,0000.51%
CHARTWELL INVESTMENT PARTNERS, LLC 187,989$11,294,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,442,0000.34%
GLOBEFLEX CAPITAL L P 18,751$1,127,0000.21%
Foundry Partners, LLC 70,357$4,227,0000.16%
View complete list of EAGLE PHARMACEUTICALS INC shareholders